SCHEMBL6833067

SCHEMBL6833067

O=C(Nc1ccc(Br)cc1C(=O)O)c1cnc(Cl)c(Cl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C2 P52895 5/20 0.56
AKR1C1 Q04828 5/20 0.56
AKR1C4 P17516 2/20 0.56
AKR1C3 P42330 2/20 0.56
KCNK2 O95069 1/20 0.54
KCNK10 P57789 1/20 0.54
ACLY P53396 1/20 0.51
MAPT P10636 3/20 0.50
KMT2A Q03164 2/20 0.50
SORT1 Q99523 2/20 0.50
DNMT3A Q9Y6K1 1/20 0.50
MEN1 O00255 1/20 0.50
ABL1 P00519 1/20 0.50
TSHR P16473 1/20 0.50
RIN1 Q13671 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
STING1 Q86WV6 1/20 0.49
ALDH1A1 P00352 1/20 0.49
GRIK1 P39086 1/20 0.48
SERPINE1 P05121 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1308635 0.82 AKR1C2 (0.65) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL7068716 0.82 ALDH1A1 (0.50) AKR1C2AKR1C1AKR1C4AKR1C3MAPT
SCHEMBL1307201 0.81 KCNK2 (0.64) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL19554141 0.80 ACLY (0.52) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL17166275 0.79 AKR1C2 (0.73) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL6833304 0.79 AKR1C2 (0.61) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL6352261 0.79 RAB9A (0.55) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL6350175 0.79 ACLY (0.79) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL9513479 0.77 MAPT (0.80) AKR1C2AKR1C1AKR1C4AKR1C3KCNK2
SCHEMBL1307332 0.76 PPARG (0.71) AKR1C2AKR1C1AKR1C4AKR1C3ACLY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 AKR1C2 2596/4885AKR1C1 2161/4885AKR1C4 2813/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.